| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| paliperidone | alpha-1a adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| paliperidone | alpha-1b adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| paliperidone | alpha-2a adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| paliperidone | alpha-2b adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| paliperidone | alpha-2c adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | agonist |
| paliperidone | dopamine d1 receptor | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.13 | approved | antagonist |
| paliperidone | dopamine d2 receptor | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.4 | approved | antagonist |
| paliperidone | dopamine d3 receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| paliperidone | dopamine d4 receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| paliperidone | histamine h1 receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| paliperidone | 5-hydroxytryptamine receptor 1a | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| paliperidone | 5-hydroxytryptamine receptor 1d | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| paliperidone | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.44 | approved | antagonist |
| paliperidone | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| paliperidone | 5-hydroxytryptamine receptor 7 | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Mood (psychological function)[MeSHID:D000339] Patient Discharge[MeSHID:D010351] Schizoaffective Disorder[MeSHID:D011618] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| click here to return to the previous page | ||||||||